Anvisa Prohibits Batches of Medicine to Treat Cancer
22 Articles
22 Articles
CartaCapital
The suspicion of the National Surveillance Agency is that pharmaceuticals are falsified
The National Agency for Health Surveillance (Anvisa) has determined the seizure and prohibition of the marketing, distribution and use of a fake batch of the medicine Dysport (botulinic toxin). The fake batch is number 025155. The decision was motivated by a statement from the company holding the registry (Beaufour Ipsen Pharmaceutical Ltd.), which identified counterfeit units in circulation. According to the agency, the fake product had a diver…
Anvisa banned on Monday 19/10 batches Z005197 and Z012354 of the immunotherapeutic keytruda, indicated for various types of cancer, suspected of falsification. The units of the two batches must be seized throughout the country.
The National Agency for Health Surveillance (Anvisa) has determined the seizure of batches Z005197 and Z012354 of the drug Keytruda (pembrolizumab), at the presentation of 100 mg/4 mL.The product is used in the treatment of different types of cancer.Related Contents:Liquid healing created in Brazil can accelerate healingAvisa free test in humans of Brazilian vaccine against malariaThe measure was published on Monday (19) in the Official Journal …
The registry company identified two batches suspected of falsification and notified the health surveillance body
Forbes, the world's most well-conceived business and economic magazine. Suspected of being counterfeit products The post Anvisa Prohibited Lots of Medicine to Treat Cancer apareceu primeiro em Forbes Brasil.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
